<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The intestinal <z:chebi fb="2" ids="35366">fatty-acid</z:chebi> binding protein-2 (FABP2) gene codes a protein responsible for the absorption of <z:chebi fb="0" ids="15904">long-chain fatty acids</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>To test whether FABP2 is a candidate gene for <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">renal disease</z:e> in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, a functional A54T polymorphism was genotyped in 1,042 Brazilians with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Patients were classified as having normoalbuminuria (urinary albumin excretion [UAE] &lt;20 microg/min; n = 529), <z:mp ids='MP_0002959'>microalbuminuria</z:mp> (UAE 20-199 microg/min; n = 217), or <z:hpo ids='HP_0000093'>proteinuria</z:hpo> (UAE &gt;199 microg/min; n = 160) </plain></SENT>
<SENT sid="3" pm="."><plain>Patients with <z:hpo ids='HP_0003774'>end-stage renal disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e>) (n = 136) were also included </plain></SENT>
<SENT sid="4" pm="."><plain>The prevalence of the TT genotype was higher in patients with renal involvement compared with those with normoalbuminuria (odds ratio [95% CI] 2.4 [1.1-5.4]) following adjustment for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> duration, BMI, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, A1C, and cholesterol levels </plain></SENT>
<SENT sid="5" pm="."><plain>The risk was similar considering different stages of renal involvement </plain></SENT>
<SENT sid="6" pm="."><plain>In a second independent patient sample (483 type 2 diabetic Caucasians residing in Massachusetts), a significant association was also observed between the TT genotype and <z:hpo ids='HP_0000093'>proteinuria</z:hpo> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ESRD</z:e> (2.7 [1.0-7.3]; P = 0.048) </plain></SENT>
<SENT sid="7" pm="."><plain>This study thus provides evidence that FABP2 confers susceptibility to <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">renal disease</z:e> in type 2 diabetic patients </plain></SENT>
</text></document>